These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10726633)

  • 21. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
    Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
    Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pure dysgerminoma of the ovary.
    Zarbo G; Giardinella S; Pepe F; Panella M; Pepe G
    Eur J Gynaecol Oncol; 1986; 7(3):192-6. PubMed ID: 3780761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes and Factors Related to the Prognosis of Pure Ovarian Dysgerminoma: A Retrospective Study of 107 Cases.
    Xu T; Sun F; Li Y
    Gynecol Obstet Invest; 2021; 86(6):494-501. PubMed ID: 34794146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysgerminoma of the ovary.
    LaPolla JP; Benda J; Vigliotti AP; Anderson B
    Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
    Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
    J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of pure stage one ovarian dysgerminoma in young women. Report of a case and review of the literature].
    Mazza D; Pozzi M; Sedati A; Vocaturo G
    Minerva Ginecol; 1999; 51(1-2):27-30. PubMed ID: 10230241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
    Jeyakumar A; Cabeza R; Hindenburg A
    Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
    Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
    Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of conservative treatment in epithelial ovarian carcinoma.
    Morice P; Wicart-Poque F; Rey A; El-Hassan J; Pautier P; Lhommé C; de Crevosier R; Haie-Meder C; Duvillard P; Castaigne D
    Cancer; 2001 Nov; 92(9):2412-8. PubMed ID: 11745298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Homogeneous dysgerminoma of the ovary. Analysis of 25 cases].
    Kojs Z; Urbański K; Jakubowicz J; Reinfuss M
    Ginekol Pol; 1995 Apr; 66(4):220-2. PubMed ID: 8529938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance policy for stage I ovarian germ cell tumors.
    Dark GG; Bower M; Newlands ES; Paradinas F; Rustin GJ
    J Clin Oncol; 1997 Feb; 15(2):620-4. PubMed ID: 9053485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian germ cell cancer: clinicopathologic analysis and outcome of 31 cases.
    Kusamura S; Teixeira LC; dos Santos MA; de Angelo Andrade LA; Campos Torres JC; Sagarra A; Deraco M; Derchain SF
    Tumori; 2000; 86(6):450-4. PubMed ID: 11218184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pure dysgerminoma of the ovary in childhood: treatment results and sequelae.
    Teinturier C; Gelez J; Flamant F; Habrand JL; Lemerle J
    Med Pediatr Oncol; 1994; 23(1):1-7. PubMed ID: 8177140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysgerminoma of the ovary: a retrospective study.
    Reddy KB; Ahuja VK; Kannan V; Vallikad E; Anantha N
    Australas Radiol; 1997 Aug; 41(3):262-5. PubMed ID: 9293677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.